University Briefs

Hewlett-Packard Co. founder David Packard has just given $2 billion to the trust he and his late wife established in 1964 and young researchers will be among the beneficiaries. The David and Lucile Packard Foundation plans to dole out 20 $500,000 awards this year and has already asked 50 top research universities to nominate two junior professors each. But only natural scientists and engineers need apply; research projects in medicine, space activity, and high-energy physics are ineligible. Th


Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Hewlett-Packard Co. founder David Packard has just given $2 billion to the trust he and his late wife established in 1964 and young researchers will be among the beneficiaries. The David and Lucile Packard Foundation plans to dole out 20 $500,000 awards this year and has already asked 50 top research universities to nominate two junior professors each. But only natural scientists and engineers need apply; research projects in medicine, space activity, and high-energy physics are ineligible. The program, which will add 20 scientists each year, will eventually pump $10 million annually into science research. Its goal: to encourage young professors to remain in research and teaching.

Could university researchers become an endangered species by 1996? That’s the sobering prediction of a recent report by NSF’s Division of Policy Research and Analysis. Numbers of American 22- year-olds (and thus numbers of potential science majors) are steadily decreasing and will bottom ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide